Abstract:Double-strand breaks (DSBs) can be efficiently removed from the DNA of higher eukaryotes by nonhomologous end-joining (NHEJ). Genetic studies implicate the DNA-dependent protein kinase (DNA-PK) in NHEJ, but the exact function of this protein complex in the rejoining reaction remains to be elucidated. We compared rejoining of DNA DSBs in a human glioma cell line, M059-J, lacking the catalytic subunit of DNA-PK (DNA-PKcs), and their isogenic but DNA-PK-proficient counterpart, M059-K. In both cell lines, rejoining of DNA DSBs was biphasic, with a fast and a slow component operating with a half-life of approximately 22 min and 12 h, respectively. Deficiency in DNA-PK activity did not alter the half-times of either of these components of rejoining but increased from 17 to 72% the proportion of DNA DSB rejoining with slow kinetics. DNA DSB rejoining was nearly complete in both cell lines, and there was only a small increase in the number of unrejoined breaks in M059-J as compared with M059-K cells after 30 h of incubation. Wortmannin radiosensitized to killing M059-K cells and strongly inhibited DNA DSB rejoining. Wortmannin did not affect the radiosensitivity to killing and produced only a modest inhibition in DNA DSB rejoining in M059-J cells, suggesting that, for these end points, DNA-PK is the principal target of the drug. These observations demonstrate that DNA-PK deficiency profoundly decreases the proportion of DNA DSB rejoining with fast kinetics but has only a small effect on the fraction remaining unrejoined. We propose that in higher eukaryotes, an evolutionarily conserved, independently active, but inherently slow NHEJ pathway is stimulated 30-fold by DNA-PKcs to rapidly remove DNA DSBs from the genome. The stimulation is expected to be of local nature and the presence of DNA-PKcs in the vicinity of the DNA DSB determines whether rejoining will follow fast or slow kinetics. Structural and regulatory functions of DNA-PKcs may mediate this impressive acceleration of DNA DSB rejoining, and regions of chromatin within a certain range from this large protein may benefit from these activities. We propose the term DNA-PK surveillance domains to describe these regions.

In-depth mapping of DNA-PKcs signaling uncovers noncanonical features of its kinase specificity

In-Depth Mapping of DNA-PKcs Signaling Uncovers Conserved Features of Its Kinase Specificity

DNA-Dependent Protein Kinase Catalytic Subunit (DNA-PKcs): Beyond the DNA Double-Strand Break Repair

DNA-PKcs: A Multi-Faceted Player in DNA Damage Response

Beyond DNA Repair: DNA-PKcs in Tumor Metastasis, Metabolism and Immunity

Secrets of DNA-PKcs beyond DNA repair

The multifaceted functions of DNA-PKcs: implications for the therapy of human diseases

Cell cycle dependence of DNA-dependent protein kinase phosphorylation in response to DNA double strand breaks.

Beyond the Trinity of ATM, ATR, and DNA-PK: Multiple Kinases Shape the DNA Damage Response in Concert With RNA Metabolism

Differential Phosphorylation of DNA-PKcs Regulates the Interplay Between End-Processing and End-Ligation During Nonhomologous End-Joining

DNA-PK as an Emerging Therapeutic Target in Cancer

Beyond DNA Repair: DNA-PK Function in Cancer

Profiling Tel1 Signaling Reveals a Non-Canonical Motif Targeting DNA Repair and Telomere Control Machineries

Repair-independent functions of DNA-PKcs protect irradiated cells from mitotic slippage and accelerated senescence

Non-Canonical Bromodomain Within Dna-Pkcs Promotes Dna Damage Response and Radioresistance Through Recognizing an Ir-Induced Acetyl-Lysine on H2ax

DNA-dependent Protein Kinase Stimulates an Independently Active, Nonhomologous, End-Joining Apparatus.

Comparative analysis of basal and etoposide-induced alterations in gene expression by DNA-PKcs kinase activity

PTEN Methylation by NSD2 Controls Cellular Sensitivity to DNA Damage

The DNA repair protein DNA-PKcs modulates synaptic plasticity via PSD-95 phosphorylation and stability

Long-Read Sequencing Annotation of the Transcriptome in DNA-PK Inactivated Cells

Molecular Pathways: Emergence of Protein Kinase CK2 (CSNK2) as a Potential Target to Inhibit Survival and DNA Damage Response and Repair Pathways in Cancer Cells